BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Healthcare

SK Bioscience Files Clinical Trial Application in Australia for GBP511 Universal Coronavirus Vaccine

Candidate designed to protect against COVID-19 variants and broader Sarbecoviruses Phase 1/2 study to enroll ~500 healthy adults, with topline results e...

October 16, 2025 | News

Ascletis’ Denifanstat (ASC40) Achieves Phase III Success in Moderate-to-Severe Acne Vulgaris

Denifanstat (ASC40) met all primary, key secondary and secondary efficacy endpoints (ITT analysis) and significantly improved moderate-to-severe acne vulga...

October 15, 2025 | News

Lundbeck’s Bexicaserin Receives Breakthrough Therapy Designation in China for Severe Childhood Epilepsies

Accelerated pathway underscores urgent need for innovative solutions for patients with devastating, childhood-onset epilepsies Novel 5HT2C mechanism des...

October 14, 2025 | News

Anthony Elgamal: Redefining First-Line Treatment in EGFR-Mutated Lung Cancer

BioPharma APAC speaks with Anthony Elgamal, Vice President of Oncology, Johnson & Johnson Innovative Medicine Asia Pacific, on th...

October 13, 2025 | Expert Insight

Jenscare’s LuX-Valve Plus Approved for Use in Greater Bay Area Under Hong Kong-Macao Medicine and Equipment Connect

Jenscare Scientific Co., Ltd. ("Jenscare" or the "Company") (HKEX: 9877), an innovative medical device company with comprehensive structural heart disease ...

October 13, 2025 | News

IHH Healthcare Launches Global Incubator Programme to Empower Early-Stage Startups

By enabling early-stage start-ups to bring breakthrough ideas to life, IHH is catalysing next-level care and driving lasting impact across the healthc...

October 13, 2025 | News

Roche and OASES Partner to Advance Healthcare Innovation in Hong Kong

Roche announced its strategic collaboration with the Office for Attracting Strategic Enterprises (OASES) to accelerate healthcare innovation and stre...

October 13, 2025 | News

Sandstone Medical Expands Easydrip™ Plus Pen Needle Portfolio to Turkey

Sandstone Medical — a SteriLance Medical sub‑brand focused on diabetes self‑injection — announced the introduction of its Easydr...

October 13, 2025 | News

Kadisco General Hospital and MindHYVE.ai™ Partner to Pioneer AI-Driven Healthcare Transformation in Ethiopia

Kadisco General Hospital (KGH), one of Ethiopia's leading private healthcare institutions, and MindHYVE.ai™, a U.S.-based pioneer in agenti...

October 09, 2025 | News

Siemens Healthineers and NUH Singapore Join Forces to Advance Ultrasound Innovation for Liver Disease Detection

Partnership will evaluate advanced ultrasound technologies to improve early detection and monitoring of Metabolic Dysfunction-Associated ...

October 07, 2025 | News

Australia’s Monash University Launches Boston Hub to Accelerate Global Biotech Partnerships

Top‑50 global university deepens its North America and Europe collaborations to fast‑track drug discovery and health innovation. Monash University, Au...

October 06, 2025 | News

HKUST Uncovers Genetic Variant Driving Alzheimer’s Risk Among Ethnic Chinese

A landmark study conducted by The Hong Kong University of Science and Technology (HKUST) has demonstrated that a genetic variant, TREM2 ...

October 06, 2025 | News

Japan Grants National Reimbursement for MedHub-AI AutocathFFR Marking a Breakthrough in AI-Driven Coronary Physiology

MedHub-AI announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved national reimbursement for the company's Autoca...

October 06, 2025 | News

Nanyang Biologics to Go Public Through Business Combination with RF Acquisition Corp II Valued at 1.5 Billion USD

Nanyang Biologics Pte. Ltd., together with its subsidiaries (collectively, the "Company", "we" or "NYB"), offers a comprehensive drug discovery platform ...

October 03, 2025 | News

Stay Connected